MERCHANTS BANCORP (MBIN): what the price assumes

In the published model solve dated 2026-Q2, anchored at $56.14, MERCHANTS BANCORP (MBIN) is priced for 10.3% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/MBIN

Headline

FieldValue
TickerMBIN
CompanyMERCHANTS BANCORP
Current price$56.14/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed10.3%
Return on equity now9.6%
ROE gap+0.7pp
Price-to-book1.11x

Solve inputs: computed at a 9.7% cost of equity with 4% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~1.1pp.

How unusual the bet is: within-range

ReferenceValue
vs own history-1.99σ
cohort percentile (of 163 peers)25
sustained it ~10 years at this level75%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and relative-multiple value, while earnings-power lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.02x3expensive
Earnings8.79x2expensive
Relative1.12x1expensive
Growth1.49x1expensive

Families that justify the price: Asset, Relative Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.0%); the inversion above states its own rate.

Per-Model Detail (n=7)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth——no—
Bank Fair Value (P/TBV)—$47.671.18xyesTBVPS $50.49 × 0.94x (ROE (TTM) 9.8% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption), credit 0.67% allowance/loans → ×0.89, NPL 2.10% → ×0.94)
Relative ValuationRelative$50.201.12xyesP/E 10x (static sector reference · 2026-04), scenarios: 8.4x / 10.0x / 11.6x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$53.651.05xyesBV/sh $50.66, ROE (TTM) 9.8%, ke 9.3%
Two-Stage Excess ReturnAsset$55.171.02xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$37.671.49xyesRev $0.5B, growth 1% (input: historical growth; tapered), Terminal P/S: 4.2x / 4.9x / 5.7x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelative——no—
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset$68.360.82xyes√(22.5 × EPS $4.10 × BVPS $50.66) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$3.4416.32xyesEPS $4.10 × (8.5 + 2×-5.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative——no—
PEG Fair ValueRelative——no—
Earnings YieldEarnings$44.321.27xyesEPS $4.10 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (dilution)1.5%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Merchants Bancorp compounds book value, and that is how a bank like this creates value. Tangible book value per share reached $38.55, against a $49.22 price, and Q1 2026 diluted EPS rose to $1.25 from $0.93 a year earlier.

The franchise is a specialty lender, not a branch bank. It originates and services multifamily and affordable-housing mortgages and runs a warehouse-lending book, funded largely by core deposits at 93% of total deposits.

The valuation is balanced. At $49.22 the asset-based and peer-multiple frames support the price while the earnings-power frame says it is full, so the bet is that book value keeps compounding faster than the specialty margins compress.

Bull Case

For a bank, capital allocation is the whole game, and Merchants Bancorp allocates well: it grows the loan book, retains earnings into tangible book value, and pays a steady dividend rather than chasing risky assets for yield. Tangible book value per share reached $38.55 in Q1 2026, the compounding metric that matters most for a financial, and the bank delivered a return on that equity well above its cost of capital, with net income of $67.7 million and diluted EPS of $1.25, up from $0.93 a year earlier and 9.6% ahead of consensus. Total assets grew to $20.32 billion as loans receivable rose 10% to $11.4 billion. A bank growing the balance sheet while compounding book value and beating estimates is deploying capital where it earns, and the board affirmed the dividend on the back of that performance.

The franchise is a focused, fee-and-spread engine rather than a generic lender. The 10-K describes the Multi-family Mortgage Banking segment, which "originates and services government sponsored mortgages for multi-family and healthcare facilities" and acts as "a fully integrated syndicator of low-income housing tax" credit funds (FY2025 10-K, accession 0001104659-26-021549). It pairs that with a warehouse-lending business the company "started in 2009 because of dislocation in the market" (FY2025 10-K, accession 0001104659-26-021549). These are specialized, relationship-driven niches where Merchants has built genuine expertise, and with total multifamily originations projected near $400 billion in 2026 and an affordable-housing mandate behind much of it, the pipeline is large and policy-supported.

The funding and credit picture supports the capital story. Deposits stood at $12.95 billion with core deposits at 93% of the total, a stable, lower-cost funding base that protects the net interest margin. Credit quality is improving, with criticized loans down 31% year over year, and revenue grew 20.1% to $175.2 million. The asset-based and relative-multiple valuation frames both support the $49.22 price, with the blended figure near $51.92, slightly above the quote. A specialty bank compounding tangible book value, funded by core deposits, with improving credit and a large origination pipeline, is the kind of financial where retained-earnings compounding does the heavy lifting over time.

Bear Case

The advantage Merchants relies on, a specialized lending niche with attractive spreads, is exactly the kind of edge that competition erodes, and the 2025 results show the erosion already biting. Full-year 2025 earnings fell roughly 39% from the prior year, and the 10-K attributes the pressure to a rising "provision for credit losses, a $76.1 million, or 34%, increase in noninterest expense, and a $5.6 million, or 1%, decrease in net interest income" (FY2025 10-K, accession 0001104659-26-021549). When net interest income falls while costs and provisions rise, the specialty spread that justifies the franchise is compressing, which is what moat erosion looks like in a bank.

The net interest margin is the pressure point. The 10-K explains that the margin depends on the cost of "deposits and other funding sources" relative to asset yields, and that it is "calculated as the annualized net interest income divided by average interest-earning assets" (FY2025 10-K, accession 0001104659-26-021549). In a competitive deposit market, holding 93% core deposits is good, but funding costs still rise when rates are high, and the multifamily and warehouse lending niches Merchants occupies are increasingly crowded as other lenders chase the same government-sponsored and affordable-housing volume. Spread compression in a specialty lender is harder to offset than in a diversified bank, because there is less product breadth to lean on.

The concentration and cyclicality are the structural risks under the capital story. The business is heavily tied to multifamily real estate and mortgage warehousing, both of which are sensitive to interest rates, real-estate values, and origination volumes that swing with the rate cycle. The earnings-power and growth-DCF valuation frames both read the stock as expensive, a signal that the current return on equity may not persist at the level the price assumes. The 2025 earnings drop is the warning: a specialty bank can post a strong quarter, as Q1 2026 did, while the multi-year trend in spreads and provisions points the other way. At a price slightly above tangible book and above the blended methods, the buyer is paying for continued book-value compounding in a niche where the spread advantage is being competed away and the credit cycle has not been tested at the current loan-book size.

Valuation

Merchants Bancorp is valued as a financial, on its ability to compound equity and return capital, and the methods land close to the price. Against the $49.22 quote, the asset-based and relative-multiple families support the price while the earnings-power and growth-DCF families read it as expensive, and the blended X-ray figure across four methods sits near $51.92, modestly above the price. The priced-in characterization is within range and value and asset-supported, which fits a bank trading near tangible book value rather than on a forward-growth multiple.

The right anchors are book value and return on equity, not the corporate-leverage lenses that do not apply to a deposit-funded balance sheet. Tangible book value per share is $38.55, so at $49.22 the stock trades around 1.3 times tangible book, a premium the bank earns only if its return on equity stays above its cost of equity. Q1 2026 diluted EPS of $1.25, annualized against that book value, implies a strong return, but the 2025 full-year earnings decline of roughly 39% shows how quickly the return can fall when provisions and funding costs rise. The solvency frame for a financial is regulatory capital and payout capacity, not net debt or interest coverage.

The honest read is that the valuation is fair, with the asset and peer-multiple support balanced against an earnings-power frame that flags the price as full. The bull case is that tangible book value keeps compounding and the specialty niches sustain above-average returns; the bear case is that spread compression, visible in the 2025 net-interest-income decline (FY2025 10-K, accession 0001104659-26-021549), pulls the return on equity down toward a level that no longer justifies a premium to book. An investor here is underwriting that the strong Q1 print is the trend rather than the 2025 earnings drop, in a specialty lender whose returns depend on a spread that competition is pressing.

Catalysts

Q1 2026 results (reported April 2026) were strong and beat. Net income rose to $67.7 million from $58.2 million a year earlier, diluted EPS climbed to $1.25 from $0.93 and came in 9.6% above consensus, revenue grew 20.1% to $175.2 million, and loans receivable rose 10% to $11.4 billion as total assets reached $20.32 billion. Tangible book value per share hit $38.55, and criticized loans fell 31% year over year, signaling improving credit. The cadence of net interest income and the provision line through 2026 is the key catalyst, given the 2025 full-year earnings decline of roughly 39%.

The origination environment is the dominant external catalyst. Total multifamily originations are projected near $400 billion in 2026, with an affordable-housing mandate behind a large share, which gives Merchants a substantial and policy-supported pipeline in its core Multi-family Mortgage Banking and warehouse-lending businesses. The pace of those originations, the gain-on-sale margins they generate, and the direction of funding costs against asset yields will determine whether the specialty spread holds or compresses further.

Capital return and credit are the steady watch items. The board affirmed its quarterly dividend on the strength of the Q1 performance, continuing the capital-return cadence, and the bank's 93% core-deposit base supports a stable funding cost. Analyst coverage is light, with roughly three analysts at a Buy consensus. The catalysts that would re-rate the stock are sustained net-interest-income growth, continued improvement in criticized loans, and book-value compounding above the rate of spread compression; the risk is a renewed earnings decline like 2025 if provisions rise or funding costs outpace asset yields.

Peer Cohorts (Per Segment, With Filing Citations)

Core business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive MBIN report on boothcheck